Pharmaceutical Chemistry, Drug Analysis and Drug Information

Projects

Projects per year 1994 2003 2005 2007 2008 2009 2010 2011 2012 2013 2026

• 12 Active
• 98 Finished

Projects per year

Search results

• Active

  OZR2617: Onderzoeksgroep Alliantie VUB-UGent: Alliance for Modulation in Epilepsy - AMIE

  Smolders, I. & Boon, P.

  1/01/14 → 31/08/26

  Project: Fundamental

  • Epilepsy 100%

• ADSI271: Interne overdrachten UZ Brussel

  Michotte, Y.

  22/12/10 → …

  Project: Fundamental

• CONO343: First Benelux Congress on Physiology and Pharmacology

  Smolders, I.

  13/12/10 → …

  Project: Fundamental

  • pharmacology 100%
  • physiology 67%
  • Pharmacology 55%
  • Membranes 16%

• ADSI249: Interne overdrachten

  Sarre, S.

  23/04/10 → …

  Project: Fundamental

• ADSP53: 13th International Conference on in vivo Methods: Monitoring Molecules in Neuroscience. 12-16 September 2010

  Michotte, Y.

  2/12/09 → …

  Project: Fundamental

  • neurology 100%
  • Neurosciences 78%
  • Microdialysis 41%
  • molecules 39%
  • Technology 24%

• CONO297: 13th International Conference on In Vivo Methods - Monitoring Molecules in Neuroscience. September 12-16, 2010

  Michotte, Y.

  16/07/09 → …

  Project: Fundamental

  • neurology 100%
  • Neurosciences 78%
  • molecules 39%

• CONI297: 13th International Conference on In Vivo Methods - Monitoring Molecules in Neuroscience. September 12-16, 2010

  Michotte, Y.

  16/07/09 → …

  Project: Fundamental

• ADSI188: Interne overdrachten UZ. Kosten 'Academische zitting en feestelijke receptie naar aanleiding van het emiraat van Prof. Dr. Guy Ebinger'.

  Michotte, Y.

  28/08/08 → …

  Project: Fundamental

• PRIBI56: Exploration of the memory enhancing effects of angiotensin IV and unravelling its mechanism of action.

  Michotte, Y. & Vauquelin, G.

  11/12/07 → …

  Project: Fundamental

  • Angiotensin IV 100%
  • angiotensins 92%

• VLO164: GIMMICS a new education model to teach knowledge and skills related to primary care practice

  Van Hecke, S., Sarre, S., De Paepe, K. & Rombaut, B.

  4/12/06 → …

  Project: Fundamental

  • pharmaceutical 100%
  • management 68%
  • Teaching 61%
  • Pharmacy practices 48%
  • geriatrics 40%

• ADSP33: Campus event 2006

  Smolders, I. & Hubloue, I.

  23/05/06 → …

  Project: Fundamental

  • event 100%
  • health 40%
  • education 27%
  • student 21%

• ADSI23: campus event 2004

  Smolders, I. & Hubloue, I.

  20/02/04 → …

  Project: Fundamental

  • event 100%
  • student 43%
• Finished

  FWOAL813: In-depth study towards the role of neuromedine U in the stress response and in stress-related CNS disorders

  Smolders, I., De Bundel, D. & Van Eeckhaut, A.

  1/01/16 → 31/12/19

  Project: Fundamental

  • neuromedin U 100%
  • Anxiety 17%
  • Hypothalamus 15%
  • Epilepsy 13%
  • Tonic-Clonic Epilepsy 12%

• SRP40: SRP (Groeiers): Unveiling the role of the cystine/glutamate antiporter (system xc-) in temporal lobe epilepsy, major depression and Parkinson’s disease

  Smolders, I. & Massie, A.

  1/03/14 → 28/02/19

  Project: Fundamental

  • Glutamic Acid 100%
  • Cystine 89%
  • Antiporters 86%
  • Temporal Lobe Epilepsy 65%
  • Parkinson Disease 60%

• IWT671: Neuromedine U (NMU) and the stress response: developing a new selective CNS active NMU receptor ligands and unraveling the role of NMU in major depression and limbic epilepsy

  Smolders, I., Ballet, S., Van Eeckhaut, A. & Caveliers, V.

  1/01/14 → 31/12/17

  Project: Fundamental

  • neuromedin U 100%
  • Epilepsy 48%
  • Central Nervous System 42%
  • Ligands 40%
  • Neurons 35%

• GIFT163: System xc- as a potential target for novel neuroprotective strategies: focus on parkinson’s disease and its psychiatric comorbidities

  Massie, A. & Smolders, I.

  19/12/13 → 31/12/16

  Project: Fundamental

  • Molecules 100%
  • Parkinson Disease 89%
  • Comorbidity 85%
  • Psychiatry 79%
  • Angst 69%

• ADSP107: Info night about the internship for farmacists 26/9/2013

  Michotte, Y., Puttemans, F. & Va Nueten, E.

  6/12/13 → 31/12/13

  Project: Fundamental

  • internship 100%
  • budget 38%
  • university teacher 34%

• FWOTM672: The absolute quantification of endogenous levels of neuromedin U and neuromedin S in vivo using nanoLC–ESI-MS/MS

  Van Eeckhaut, A. & Van Wanseele, Y.

  1/10/13 → 30/09/17

  Project: Fundamental

  • neuromedin S 100%
  • neuromedin U 85%
  • Fees and Charges 61%
  • Neuromedin S 36%
  • Neuromedin U 32%

• ADSI393: Awarded grants

  Van Eeckhaut, A.

  29/08/13 → 29/08/17

  Project: Fundamental

• ADSI389: Interne overboekingen (o.a. analyses van UZ, en overboeking van prof. Poelaert

  Smolders, I.

  24/06/13 → 24/06/17

  Project: Fundamental

• FJU16: Psychopathologie en psychofarmaca.

  Soyez, V., Smolders, I. & Van West, D.

  7/06/13 → 31/12/13

  Project: Fundamental

• IWT616: Major Depression - Cystine/glutamate antiporter

  Massie, A. & Smolders, I.

  1/01/13 → 31/12/16

  Project: Fundamental

  • Antiporters 100%
  • Cystine 90%
  • Glutamic Acid 85%
  • Students 39%
  • Antidepressive Agents 37%

• OZR2423: New funding model research: ZAP start fund 2012

  Van Eeckhaut, A.

  1/10/12 → 1/10/16

  Project: Fundamental

• OZR2433: Research unit neurosciences: one time backpack funding

  De Keyser, J. & Michotte, Y.

  1/10/12 → 30/09/13

  Project: Fundamental

  • Neurosciences 100%
  • Biotechnology 27%
  • Neurology 24%
  • Resuscitation 22%
  • Molecular Biology 18%

• FWOUW12: Study of the role of the angiotensin modulatory system in the mechanisms linking epileptic seizures to hypertension ()

  Smolders, I.

  13/08/12 → 31/12/12

  Project: Fundamental

  • Angiotensins 100%
  • Seizures 67%
  • Hypertension 56%

• GIFT132: Prize ING

  Smolders, I., Massie, A. & Pardoen, V.

  4/06/12 → 4/06/16

  Project: Fundamental

  • World War I 100%

• FWOAL645: Unravelling the role of system xc- in epileptogenesis

  Smolders, I. & Massie, A.

  1/01/12 → 31/12/15

  Project: Fundamental

  • Antiporters 100%
  • Cystine 98%
  • Glutamic Acid 83%
  • Cysteine 41%
  • Amino Acid Transport Systems 34%

• FWOAL621: IGF-I and mild hypothermia as new therapies for focal cerebral ischemia

  De Keyser, J., Brouns, R., Hachimi-Idrissi, S., Kooijman, R. & Sarre, S.

  1/01/12 → 31/12/15

  Project: Fundamental

  • hypothermia 100%
  • ischemia 95%
  • insulin-like growth factor I 93%
  • therapeutics 66%
  • Insulin-Like Growth Factor I 43%

• IWT571: UHPLC met elektrochemische detectie voor in vivo neurochemisch onderzoek

  Van Eeckhaut, A.

  1/01/12 → 31/12/15

  Project: Fundamental

  • Huns 100%
  • Postal Service 80%
  • Students 51%
  • Leiden 42%
  • Expertise 28%

• OZR2220: Investigation of the neuroprotective effect of hypothermia in the endotheline-1 rat model for transient focal cerebral ischemia.

  Michotte, Y.

  1/09/11 → 30/11/11

  Project: Fundamental

  • Transient Ischemic Attack 100%
  • Hypothermia 95%
  • Neuroprotective Agents 92%

• ADSI289: Research gelden Gepts-fonds

  Sarre, S.

  29/06/11 → 29/06/15

  Project: Fundamental

• IWT532: In vivo monitoring van neuropeptiden tijdens epileptische aanvallen met nano LC-MS/MS en karakterisering van hun mogelijke anticonvulsieve rol.

  Smolders, I., Van Eeckhaut, A. & Maes, K.

  1/01/11 → 31/12/14

  Project: Fundamental

  • trucks 100%
  • Dialysis Fluid 62%
  • Anticonvulsant 26%
  • Glass 15%
  • Peptide 13%

• IWT517: Systeem xc- als innovatief aangrijpingspunt voor de behandeling van temporaalkwab epilepsie.

  Smolders, I. & Massie, A.

  1/01/11 → 31/12/14

  Project: Fundamental

  • Antiporters 100%
  • Cystine 90%
  • Glutamic Acid 73%
  • Amino Acid Transport Systems 32%
  • Epilepsy 29%

• PRIBI64: Characterization of the role of the cystine/glutamate aniporter or system xc and other glial glutamate transporters in multiple sclerosis: possible link with B2-adregenic receptor dysfunction.

  Massie, A., De Keyser, J., Laureys, G. & Clinckers, R.

  1/01/11 → 31/12/12

  Project: Fundamental

  • Cystine 100%
  • Glutamic Acid 67%
  • Amino Acid Transport System X-AG 62%
  • Antiporters 59%
  • Multiple Sclerosis 57%

• OZR2097: The role of the locus coeruleus and hippocampal noradrenergic neurotransmission in the anti-epileptic effect of of vagus nerve stimulation.

  Smolders, I.

  1/01/11 → 31/12/14

  Project: Fundamental

  • Locus Coeruleus 100%
  • Vagus Nerve Stimulation 71%
  • Synaptic Transmission 50%
  • Budgets 47%
  • Adrenergic Neurons 31%

• FWOAL595: The role of astrocytic beta-2 adrenergic receptors in pathophsyiological mechanisms relevant for multiple sclerosis

  De Keyser, J. & Clinckers, R.

  1/01/11 → 31/12/13

  Project: Fundamental

  • Adrenergic beta-2 Receptors 100%
  • Multiple Sclerosis 95%
  • Adrenergic Receptors 34%
  • Astrocytes 33%
  • Demyelinating Diseases 9%

• PRIBI65: Unveiling the role of the cystine/glutamate antiporter (system Xc) in hippocampal functioning, mechanisms of epilepsy and its comorbidities: a new era for future drug treatment.

  Smolders, I., Massie, A. & Michotte, Y.

  1/01/11 → 31/12/13

  Project: Fundamental

  • Antiporters 100%
  • Cystine 90%
  • Glutamic Acid 66%
  • Epilepsy 42%
  • Comorbidity 22%

• OZR2105: Oxidative stress and excitotoxicity in Parkinson's disease: role of glutamate transporters as possible targets for the curative properties of theanine, a component of green tea

  Massie, A.

  1/10/10 → 30/09/13

  Project: Fundamental

  • Amino Acid Transport System X-AG 100%
  • theanine 51%
  • Oxidative Stress 44%
  • Parkinson Disease 37%
  • Tea 33%

• OZR2138: The use of nano LC-MS/MS for the quantification of brain neuropeptides possibly involved in epileptic seizure generation

  Smolders, I.

  1/10/10 → 31/12/10

  Project: Fundamental

  • Dialysis Fluid 100%
  • Glass 25%
  • Peptide 21%
  • Volume 21%
  • Drug 19%

• OZR2102: Search for anticonvulsant and antiepileptogenic neuropeptides as strategy for the development of innovative future antiepileptic drugs

  Smolders, I.

  1/10/10 → 30/09/14

  Project: Fundamental

  • Anticonvulsant 100%
  • Drugs 70%
  • Peptide 16%

• OZR2139: System xc- as possible target for the development of new pharmacotherapies for the treatment of limbic epilepsy

  Smolders, I.

  1/10/10 → 31/12/10

  Project: Fundamental

  • Glutamic Acid 100%
  • Cystine 59%
  • Status Epilepticus 52%
  • Anticonvulsants 43%
  • Seizures 35%

• OZR2148: IWT Overbruggingsbeurs (4 maanden): Titel wordt later aangevuld

  Michotte, Y.

  1/09/10 → 31/12/10

  Project: Fundamental

• GIFT119: Prize "Burggravin Valine de Spoelberch"

  Michotte, Y.

  3/06/10 → 31/12/13

  Project: Fundamental

  • Angiotensin Receptors 67%
  • Valine 65%
  • Epilepsy 46%
  • Parkinson Disease 45%
  • Learning 40%

• OZR2038: Odysseus

  De Keyser, J., Kooijman, R., Clinckers, R., Demol, F. & Wilczak, N.

  1/01/10 → 31/12/12

  Project: Policy Based

  • Multiple Sclerosis 100%
  • Astrocytes 52%
  • Energy Metabolism 51%
  • Distemper 44%
  • Virus Diseases 41%

• FWOAL569: The role of the locus coeruleus and hippocampal noradrenergic neurotransmission in the anti-epileptic effect of of vagus nerve stimulation.

  Smolders, I., Meurs, A., Clinckers, R., Boon, P., Raedt, R. & Vonck, K.

  1/01/10 → 31/12/13

  Project: Fundamental

  • Locus Coeruleus 100%
  • Adrenergic Neurons 62%
  • Pilocarpine 59%
  • Seizures 46%
  • Norepinephrine 40%

• OZR2030: Research into treatment strategies for depression and DBS-induced depression in Parkinson's disease

  Sarre, S. & El Arfani, A.

  1/01/10 → 31/12/10

  Project: Fundamental

  • brain 100%
  • Parkinson Disease 99%

• OZR1926: Investigation into the mechanism(s) of action of new strategies to treat Parkinson's disease.

  Sarre, S.

  1/01/10 → 31/12/14

  Project: Fundamental

  • Parkinson Disease 100%
  • Subthalamic Nucleus 90%
  • Budgets 81%
  • Neuroprotective Agents 36%
  • Neuroprotection 25%

• FWOAL562: In search for anticonvulsive and antiepileptogenic neuropeptides as a strategy for innovative future antiepileptic drug development

  Smolders, I., Michotte, Y., Meurs, A. & Boon, P.

  1/01/10 → 31/12/13

  Project: Fundamental

  • Anticonvulsants 100%
  • Pilocarpine 87%
  • Neuropeptides 84%
  • Seizures 82%
  • Epilepsy 59%

• OZR2001: Study of the role of angiotensin fragments in renal hemodynamics and sodium excretion

  Dupont, A. & Smolders, I.

  1/11/09 → 30/04/10

  Project: Fundamental

  • angiotensin A 100%
  • des-Asp(1)-des-Arg(2)-Ile(5)-angiotensin II 98%
  • Angiotensins 82%
  • Sodium 72%
  • Hemodynamics 64%

• OZR2011: Research for neuroprotective drugs with neurotrophic features for the treatment of Parkinson's disease

  Sarre, S.

  1/10/09 → 31/03/10

  Project: Fundamental

  • Parkinson Disease 100%
  • Neuroprotective Agents 91%
  • L Forms 22%
  • Antiparkinson Agents 20%
  • Lewy Bodies 19%